USD10
MDGL Shares
About Madrigal PharmaceuticalsMadrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
USD10
MDGL Shares
About Madrigal PharmaceuticalsMadrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$12.76B
OPEN PRICE
$538.85
LOW (1Y)
$286.44
HIGH (1Y)
$615.00
LOW (24H)
$536.01
HIGH (24H)
$560.09
VOLUME (24H)
$528.31K
121.66%
Price history
Time | Price | Change |
|---|---|---|
Today | $538.85 | |
1 Day | $538.01 | |
1 Week | $537.82 | |
1 Month | $508.97 | |
1 Year | $330.94 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.